Sociodemographic, sexual and healthcare behaviour characteristics, and the prevalence of self-reported, clinically diagnosed genital warts among women and men aged 18–45 years in the Baltic countries in 2011–2013
| All (N=7760) | Estonia (n=3188) | Latvia (n=3050) | Lithuania (n=1522) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Men (n=2746) | Women (n=5014) | Men (n=1221) | Women (n=1967) | Men (n=1525) | Women (n=1525) | Women (n=1522) | |||
| n | Per cent | n | Per cent | Per cent | Per cent | Per cent | Per cent | Per cent | |
| Age (years) | |||||||||
| 18–19 | 181 | 7 | 262 | 5 | 4 | 2 | 11 | 9 | 5 |
| 20–24 | 579 | 21 | 906 | 18 | 20 | 16 | 26 | 18 | 20 |
| 25–29 | 479 | 17 | 850 | 17 | 16 | 16 | 16 | 16 | 16 |
| 30–34 | 421 | 15 | 846 | 17 | 14 | 18 | 14 | 16 | 17 |
| 35–39 | 438 | 16 | 854 | 17 | 19 | 20 | 11 | 13 | 15 |
| 40+ | 648 | 24 | 1296 | 26 | 27 | 27 | 22 | 29 | 27 |
| Married or cohabiting | 1517 | 55 | 3206 | 64 | 65 | 74 | 44 | 56 | 59 |
| Ethnicity (main*) | 1889 | 69 | 3831 | 76 | 77 | 76 | 63 | 65 | 88 |
| Employed | 1855 | 68 | 3152 | 63 | 73 | 65 | 60 | 60 | 64 |
| Coping with household income: difficult or very difficult | 1208 | 45 | 2336 | 47 | 36 | 38 | 51 | 58 | 49 |
| Ever smoked | 1881 | 69 | 2315 | 46 | 67 | 48 | 69 | 47 | 45 |
| Age at first sexual intercourse ≤15 years | 456 | 18 | 487 | 10 | 18 | 13 | 20 | 9 | 7 |
| Lifetime number of sexual partners ≥5 | 1281 | 53 | 1480 | 33 | 55 | 44 | 51 | 30 | 20 |
| History of STI other than genital warts (yes)† | 269 | 10 | 856 | 17 | 13 | 29 | 7 | 12 | 7 |
| Reproductive/genital healthcare visit (ever) | 1152 | 42 | 4510 | 90 | 44 | 90 | 39 | 92 | 90 |
| Hormonal contraceptive use (ever) | NA | NA | 1205 | 43 | NA | 73 | NA | 55 | 51 |
| Ever thought they had a lump or a bump that might have been a genital wart, n, % (95% CI) | |||||||||
| Crude prevalence | 166 | 6.0 (5.2 to 7.0) | 353 | 7.0 (6.4 to 7.8) | 8.0 (6.6 to 9.7) | 10.1 (8.9 to 11.5) | 4.5 (3.5 to 5.6) | 5.2 (4.2 to 6.5) | 4.9 (3.9 to 6.1) |
| Weighted prevalence | 149 | 5.8 (4.9 to 6.7) | 497 | 6.8 (6.3 to 7.4) | 8.1 (6.5 to 10.0) | 10.2 (9.1 to 11.4) | 4.4 (3.5 to 5.5) | 5.2 (4.2 to 6.4) | 4.9 (4.2 to 5.7) |
| Self-reported history of clinically diagnosed genital warts during lifetime, n, % (95% CI) | |||||||||
| Crude prevalence | 65 | 2.4 (1.9 to 3.0) | 154 | 3.1 (2.6 to 3.6) | 2.9 (2.1 to 4.0) | 4.5 (3.7 to 5.5) | 2.0 (1.4 to 2.8) | 2.8 (2.1 to 3.8) | 1.4 (0.9 to 2.2) |
| Weighted prevalence | 57 | 2.2 (1.7 to 2.9) | 208 | 2.9 (2.5 to 3.3) | 2.8 (1.9 to 4.0) | 4.6 (3.8 to 5.5) | 1.9 (1.3 to 2.6) | 2.9 (2.0 to 3.6) | 1.5 (1.2 to 2.0) |
| Self-reported history of clinically diagnosed genital warts during the last 12 months, n, % (95% CI) | |||||||||
| Crude prevalence | 14 | 0.5 (0.3 to 0.9) | 30 | 0.6 (0.4 to 0.9) | 0.7 (0.3 to 0.9) | 0.8 (0.5 to 1.3) | 0.4 (0.2 to 0.9) | 0.6 (0.3 to 1.1) | 0.4 (0.2 to 0.9) |
| Weighted prevalence | 12 | 0.5 (0.3 to 0.8) | 41 | 0.6 (0.4 to 0.8) | 0.6 (0.3 to 1.3) | 0.8 (0.5 to 1.2) | 0.4 (0.2 to 0.8) | 0.6 (0.3 to 1.1) | 0.4 (0.2 to 0.7) |
*Main ethnic group: Estonians, Latvians, Lithuanians.
†STI, sexually transmitted infection; includes genital chlamydial infection, gonorrhoea, trichomoniasis, herpes and/or syphilis ever diagnosed by a physician (does not include HIV infection).